###begin article-title 0
Genetic Architecture of Intrinsic Antibiotic Susceptibility
###end article-title 0
###begin p 1
Conceived and designed the experiments: HG ST. Performed the experiments: HG AKH. Analyzed the data: AKH. Wrote the paper: HG AKH ST.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Antibiotic exposure rapidly selects for more resistant bacterial strains, and both a drug's chemical structure and a bacterium's cellular network affect the types of mutations acquired.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 125 141 125 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 625 632 625 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 125 141 <span type="species:ncbi:562">Escherichia coli</span>
###xml 625 632 <span type="species:ncbi:562">E. coli</span>
To better characterize the genetic determinants of antibiotic susceptibility, we exposed a transposon-mutagenized library of Escherichia coli to each of 17 antibiotics that encompass a wide range of drug classes and mechanisms of action. Propagating the library for multiple generations with drug concentrations that moderately inhibited the growth of the isogenic parental strain caused the abundance of strains with even minor fitness advantages or disadvantages to change measurably and reproducibly. Using a microarray-based genetic footprinting strategy, we then determined the quantitative contribution of each gene to E. coli's intrinsic antibiotic susceptibility. We found both loci whose removal increased general antibiotic tolerance as well as pathways whose down-regulation increased tolerance to specific drugs and drug classes. The beneficial mutations identified span multiple pathways, and we identified pairs of mutations that individually provide only minor decreases in antibiotic susceptibility but that combine to provide higher tolerance.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 139 146 <span type="species:ncbi:562">E. coli</span>
Our results illustrate that a wide-range of mutations can modulate the activity of many cellular resistance processes and demonstrate that E. coli has a large mutational target size for increasing antibiotic tolerance. Furthermore, the work suggests that clinical levels of antibiotic resistance might develop through the sequential accumulation of chromosomal mutations of small individual effect.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 154 157 154 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Levy1">[1]</xref>
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Walsh1">[2]</xref>
###xml 304 307 304 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Lenski1">[3]</xref>
###xml 552 555 552 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Drlica1">[4]</xref>
###xml 698 701 698 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Davies1">[5]</xref>
###xml 141 146 <span type="species:ncbi:9606">human</span>
Antibiotic tolerance, the decreased efficacy of antimicrobial agents in eliminating infections, is a serious and worsening global problem in human health [1], [2]. During the long history of chemical warfare between microbes, the genomes of many bacteria have evolved to encode multiple counter-measures [3]. Moreover, a level of antibiotic tolerance that allows some bacteria to survive an initial exposure gives the population the opportunity to accumulate mutations, leading to higher levels of tolerance and potentially to full clinical resistance [4]. Much of the literature on antibiotic resistance focuses on tolerance to the high antibiotic levels typically used in a clinical setting (see [5] for an exception).
###end p 9
###begin p 10
###xml 524 527 524 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Rybak1">[6]</xref>
###xml 538 545 <span type="species:ncbi:9606">patient</span>
Even in clinical practice, however, bacteria commonly experience sub-inhibitory drug concentrations, which may be capable of reducing the growth rate but are lower than the minimum inhibitory concentration (MIC). The cyclical dosing regimen for most antibiotics, for example, may cause the drug's plasma concentration to approach the MIC for short intervals during treatment. Furthermore, micro-niches within the host, such as epidermis, lungs, and joints, may attain significantly lower drug concentrations than the plasma [6]. Finally, patient non-compliance with the prescribed frequency and duration of antibiotic use can allow plasma levels to fall below the MIC. In such circumstances, selection for more tolerant variants is strong.
###end p 10
###begin p 11
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-DCosta1">[7]</xref>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Fajardo1">[8]</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-ThieleBruhn1">[9]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Watkinson1">[10]</xref>
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Onan1">[11]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Schwartz1">[12]</xref>
Outside clinical settings, environments containing antibiotics, especially at sub-inhibitory concentrations, abound. Soil contains numerous antibiotic-producing species [7], which generate compounds with roles in killing competitors as well as in inter- and intra-species signaling [8]. Antibiotics also enter the soil through the use of manure from livestock whose feed was supplemented with antibiotics [9], and wastewater can contain multiple drugs at concentrations in the range of ng/L, even after treatment [10]. The rise in environmental antibiotic levels resulting from the widespread use of antibiotics has selected for resistant strains in both soil [11] and aqueous [12] environments.
###end p 11
###begin p 12
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-McKeegan1">[13]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Walsh2">[14]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Wright1">[15]</xref>
###xml 513 534 513 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Deurenberg1">[16]</xref>
###xml 634 641 634 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 705 709 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gyrA</italic>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">parC</italic>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Chenia1">[17]</xref>
###xml 513 534 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 634 641 <span type="species:ncbi:562">E. coli</span>
Diverse mechanisms including drug target modification, enzymatic drug inactivation, and intracellular drug concentration reduction can lead to antibiotic resistance [13], [14], [15]. A variety of sources, such as lateral gene transfer and chromosomal mutations, can provide the underlying genetic changes, and clinically resistant strains often contain multiple alterations. The plasmids, transposons, and mobile chromosome cassettes that contribute to antibiotic resistance, including methicillin resistance, in Staphylococcus aureus are examples of well-studied extrinsic elements that confer antibiotic resistance [16]. Similarly, E. coli strains can receive contributions to quinolone resistance from gyrA and parC mutations as well as a reduction in outer membrane porins and an increase in drug efflux pump activity [17]. Cases where multiple mutations work collectively to give resistance, while of clear importance, are not well understood, in part because the range of mutations that can increase a particular bacterium's antibiotic tolerance is rarely known.
###end p 12
###begin p 13
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Gomez1">[18]</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Fajardo2">[19]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Tamae1">[20]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Breidenstein1">[21]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Schurek1">[22]</xref>
The effect of mutation in altering genetic programs and modulating susceptibility, however, is starting to receive attention. Multiple groups have assayed the drug susceptibility of bacteria containing families of simple genetic perturbations such as single gene deletions or transposon insertions [18], [19], [20], [21], [22]. These studies found that large numbers of genes influence drug susceptibility, including many whose dominant function is not resistance. Moreover, while some genes, such as those that code for drug efflux pumps, contribute to resistance to a wide range of compounds, many others are drug or drug class specific.
###end p 13
###begin p 14
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Albert1">[23]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-ElGarch1">[24]</xref>
Most previous work focused on identifying genes whose removal changes the MIC by some predetermined threshold, usually 2-fold. The increasing number of examples of multiple genetic perturbations combining to confer high levels of resistance [23], [24], however, suggests that mutations of even mild individual benefit are of potential clinical relevance. As such, we decided to take a complementary approach to identifying mutations that alter antibiotic susceptibility.
###end p 14
###begin p 15
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
Rather than testing MIC directly, we searched a library of transposon-mutagenized cells [25] for those with a competitive advantage at drug concentrations that moderately reduced the parental strain's growth rate. Competitive growth of the mutants for multiple generations caused the abundance of strains with even minor fitness advantages or disadvantages to change measurably and reproducibly. Applying microarray-based genetic footprinting [25] to the resulting population allowed us to identify and quantify the genetic determinants contributing to both antibiotic sensitivity and tolerance.
###end p 15
###begin p 16
The experimental conditions proved to be particularly conducive to finding mutants fitter than the wildtype in the presence of antibiotics, enabling us to find many genes whose inactivation increases antibiotic tolerance. Analysis of individual mutants revealed a non-perfect correlation between a strain's fitness advantage in the conditions of the selection and its MIC in similar conditions. Explanations for and implications of the variations are discussed.
###end p 16
###begin title 17
Results and Discussion
###end title 17
###begin title 18
Selection of Transposon Insertion Mutants under Sub-inhibitory Antibiotic Exposure
###end title 18
###begin p 19
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g001">Figure 1</xref>
###xml 275 282 275 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005629-t001">Table 1</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Scott1">[26]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Walsh3">[27]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Baquero1">[28]</xref>
###xml 656 663 656 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005629-t001">Table 1</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
To characterize the contribution of all genetic loci to antibiotic tolerance, we exposed a collection of mutants, each with a single transposon insertion, to sub-inhibitory drug concentrations (Figure 1). We chose 17 antibiotics that possess a range of mechanisms of action (Table 1). These drugs inhibit various cellular functions including the synthesis of proteins, nucleic acids, folic acid, and cell wall [26], [27]. As intermediate antibiotic concentrations are typically the most selective for resistance [28], during the selections, we used antibiotic concentrations that impaired but did not completely inhibit the growth of the wild-type strain (Table 1). Using a sensitive microarray-based strategy [25], we then quantified the change in prevalence of different transposon insertion mutants in parallel.
###end p 19
###begin title 20
Overview of experimental protocol.
###end title 20
###begin p 21
###xml 56 57 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 106 110 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
###xml 284 291 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005629-t001">Table 1</xref>
###xml 547 551 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
###xml 660 664 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
###xml 896 899 884 887 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 985 994 973 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s002">Figure S1</xref>
###xml 1417 1426 1405 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s003">Figure S2</xref>
###xml 1483 1492 1471 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s004">Figure S3</xref>
(A) An aliquot of a library containing approximately5x105 mutants each with a single transposon insertion [25] was taken from frozen stock, grown overnight in LB, pelleted, washed, and resuspended at 2% inoculum in fresh M9-media containing an antibiotic at the chosen concentration (Table 1). Each day, an aliquot was frozen, and 2% of the culture was transferred to fresh media to continue the selection. Genetic footprinting was performed on frozen samples to amplify the region of genomic DNA adjacent to the transposon in each of the mutants [25]. DNA was subsequently labeled and hybridized with a reference of labeled genomic DNA to spotted microarrays [25]. (B) Dose response curves were used to select drug concentrations. For each antibiotic, fresh media containing various drug concentrations was inoculated with overnight culture of the wild-type strain. Growth was monitored using OD600 readings. Shown are the curves for amikacin; curves for all other antibiotics are in Figure S1. Typically, we selected moderately inhibitory drug concentrations that reduced the growth after 14 hours by 30-50%. (C) Separation of DNA on an agarose gel provided a qualitative depiction of the population diversity after each day of selection. Shown are the amplified Tn-adjacent DNA from all seven days of one of the ampicillin selections. Selections performed without antibiotic showed no discernable banding pattern (Figure S2). Gel images for all selections with antibiotics are in Figure S3.
###end p 21
###begin title 22
Information related to each antibiotic used in this study.
###end title 22
###begin p 23
Two samples from day 2 and one from day 3 were hybridized and analyzed.
###end p 23
###begin p 24
###xml 148 169 148 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kishony1">[29]</xref>
###xml 776 786 776 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s020">Dataset S1</xref>
###xml 1005 1015 1005 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s005">Figures S4</xref>
###xml 1016 1016 1016 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s006"/>
###xml 1016 1016 1016 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s007"/>
###xml 1016 1016 1016 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s008"/>
###xml 1016 1016 1016 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s009"/>
###xml 1016 1016 1016 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s010"/>
###xml 1016 1016 1016 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s011"/>
###xml 1016 1019 1016 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s012">S11</xref>
The final distribution was compared to both the original, unselected library and to the library selected in the same media without antibiotics (See Materials and Methods). Comparison to populations grown in M9 media without antibiotics allowed media and antibiotic effects to be distinguished. As some external stresses such as low-level antibiotic exposure can ameliorate the deleterious nature of some mutations [29], the abundance of slow growing mutants may increase in cultures with antibiotics compared to cultures without antibiotics. Comparison to the unselected library allowed the identification of insertion locations whose prevalence had increased or decreased during the experiment and reduced the chances of classifying slow-growing mutants as less susceptible. Dataset S1 lists the loci whose disruption caused a significant fitness change in each of the drugs tested. Heatmaps displaying the data for loci whose disruptions were significant in individual drugs and classes of drugs are in Figures S4-S11.
###end p 24
###begin title 25
Validation of Global Fitness Profiling
###end title 25
###begin p 26
###xml 119 128 119 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s013">Tables S1</xref>
###xml 129 129 129 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s014"/>
###xml 129 129 129 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s015"/>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s016">S4</xref>
Comparison to the literature indicates that we found many genes whose removal is known to increase susceptibility (See Tables S1-S4). However, attempts to set significance thresholds that captured all such genes resulted in an unacceptable number of false positives. As shown later in this work, some mutations confer such a high degree of fitness in particular antibiotics that strains possessing these mutations rapidly take over the population. The existence of such highly fit mutants makes it difficult to distinguish neutral transposon insertion locations from some with a slightly deleterious effect because mutants with either are quickly lost from the population. Consequently, when selecting genes for additional study, an emphasis was placed on those whose removal increases antibiotic tolerance.
###end p 26
###begin p 27
###xml 190 211 190 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s001">Text S1</xref>
###xml 274 281 274 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en mass</italic>
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
To quantify the strength of the identified loci, we subjected the wild-type parental strain to direct competition with mutant strains in conditions that mimicked those of the selection (See Materials and Methods and Text S1). The mutants tested behaved as expected from the en mass library selections (Figure 2).
###end p 27
###begin title 28
Selection rates during direct competitions.
###end title 28
###begin p 29
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 96 97 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Travisano1">[87]</xref>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 118 119 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 301 302 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 426 435 426 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trpA::kan</italic>
###xml 546 555 546 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trpA::kan</italic>
Selection rates (generations/day) were calculated as (log2(A(t1)/A(t0))-log2(B(t1)/B(t0)))/(t1-t0) [87]. A(t0) and B(t0) are, respectively, the mutant and the wild-type population sizes at t0, the beginning of the competition, and A(t1) and B(t1) are the mutant and the wild-type population sizes at t1, the end of the competition. Shown are the average and standard deviation of three repetitions. The selection rate for the trpA::kan mutant in amikacin was calculated after two days of enrichment to correspond with the samples hybridized. The trpA::kan strain's reliance on tryptophan from lysed wild-type cells prevents the mutant from taking over the culture, and during additional transfers, the wild-type strain showed a competitive advantage. Selection rates for other strains were insensitive to the competition duration.
###end p 29
###begin p 30
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s001">Text S1</xref>
###xml 914 923 890 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s017">Tables S5</xref>
###xml 924 924 900 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s018"/>
###xml 924 926 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s019">S7</xref>
We also determined the MICs for a representative set of individual mutants lacking genes judged to have a significant role in antibiotic susceptibility. The relative efficiency of our MIC measurement method (see Text S1) allowed us to analyze a larger set of strains than would have been possible using only the more labor-intensive direct competitions. As the initial selection process did not require a change in MIC, the MICs provide complementary information about each mutation's effect, and we did not expect all beneficial (or deleterious) disruptions to cause an increase (or decrease) in MIC. The most common result was a change in MIC of 1.5 fold (the smallest change detectable with our technique) in the expected direction-an increase (or decrease) for a locus whose disruption was beneficial (or deleterious). We observed increases up to approximately5-fold and decreases down to approximately7-fold (Tables S5-S7).
###end p 30
###begin title 31
Genes Exert Class-Specific Effects on Antibiotic Susceptibility
###end title 31
###begin p 32
###xml 232 240 232 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g003">Figure 3</xref>
###xml 696 703 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 731 735 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Leclercq1">[30]</xref>
###xml 854 861 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 696 703 <span type="species:ncbi:562">E. coli</span>
###xml 854 861 <span type="species:ncbi:562">E. coli</span>
Excluding the 30 genes identified as having general roles in antibiotic susceptibility (see below), only antibiotics of the same class have a substantial number of beneficial or deleterious transposon insertion locations in common (Figure 3). Some functional classes of antibiotics, particularly the beta-lactams and the aminoglycosides, have strong class-specific signatures, while other classes, such as the quinolones, have few loci in common. The number of loci impacting growth at the sub-inhibitory drug concentrations tested varied greatly from the low hundreds for the aminoglycosides down to zero for fusidic acid and erythromycin, inhibitors of the 50S subunit of the ribosome to which E. coli is intrinsically resistant [30]. The mutational target size observed likely depends on both the antibiotic concentration assayed and the structure of E. coli's cellular network. For example, redundant pathways may mask the contribution of some genes to antibiotic tolerance.
###end p 32
###begin title 33
Overlap between genes influencing fitness in partially inhibitory concentrations of different antibiotics.
###end title 33
###begin p 34
###xml 117 138 117 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 201 209 201 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g007">Figure 7</xref>
###xml 330 337 330 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 330 337 <span type="species:ncbi:562">E. coli</span>
Squares on the main diagonals indicate the number of genes whose disruption caused a significant fitness effect (See Materials and Methods). Genes causing general changes in antibiotic susceptibility (Figure 7) were excluded. The lower left (upper right) triangle reports on genes whose disruption was beneficial (deleterious) to E. coli in the presence of the indicated antibiotic. Off-diagonal squares indicate how many genes caused significant fitness changes in both antibiotics when disrupted. The shading shows the likelihood of an overlap of the indicated size or larger occurring by chance and was calculated using the hypergeometric distribution. P-values were corrected for multiple testing. Erythromycin and fusidic acid are not shown as the only genes whose disruption affected fitness caused general changes in susceptibility.
###end p 34
###begin p 35
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Williams1">[31]</xref>
###xml 565 573 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g004">Figure 4</xref>
###xml 594 602 591 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g005">Figure 5</xref>
###xml 649 657 646 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g006">Figure 6</xref>
The observation that disruptions caused increases in fitness during drug exposure is characteristic of antagonistic pleiotropy [31], which reflects an evolutionary tradeoff for increased drug tolerance at the consequence of other traits. A large number of disruptions fell into this category (336), suggesting that the bacterium contains a large mutational target size for increasing drug tolerance. To elucidate the pathways and mechanisms contributing to susceptibility and tolerance, we analyzed the identified loci for three drug classes - the aminoglycosides (Figure 4), the beta-lactams (Figure 5), and the folic acid biosynthesis inhibitors (Figure 6) - in more detail. In each case, the data indicate the major pathways involved and the many ways that mutations can modulate those pathways.
###end p 35
###begin title 36
Disruption of electron transport and oxidative respiration reduces susceptibility to aminoglycosides.
###end title 36
###begin p 37
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Eisen1">[84]</xref>
###xml 194 215 194 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 218 226 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s013">Table S1</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kohanski1">[33]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kohanski1">[33]</xref>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Johnson1">[88]</xref>
(A) The heatmaps, in which hierarchical clustering was used to order both the genes and the drugs [84], show loci whose disruption changed susceptibility to all four aminoglycosides tested (See Materials and Methods). Table S1 lists the genes with annotations. (B) Of the 73 transposon insertions regions identified as beneficial in all four aminoglycosides, the 48 shown are expected to reduce Fenton reaction-based oxidative damage. Following exposure to lethal concentrations of bactericidal antibiotics, the oxidative electron transport chain depletes the NADH pool, generating high levels of superoxide, which removes iron from iron-sulfur clusters [33]. The free iron subsequently generates hydroxyl radicals through the Fenton reaction [33]. Removal of key catabolic enzymes should shrink the NADH pool and reduce the flux through the electron transport chain. The media used lacks cysteine, the sulfur donor for iron-sulfur center synthesis [88], so disruption of cysteine biosynthesis should reduce the availability of sulfur for iron-sulfur centers. The iron-sulfur center synthesis genes shown are not specific for NADH dehydrogenase I, and their disruption should reduce the number of iron-sulfur clusters throughout the cell. Q: ubiquinone; FMN: flavin mononucleotide; FAD: flavin adenine dinucleotide
###end p 37
###begin title 38
Reduced flagella synthesis is advantageous in beta-lactams.
###end title 38
###begin p 39
###xml 106 127 103 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 193 197 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Eisen1">[84]</xref>
###xml 199 207 196 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s014">Table S2</xref>
###xml 586 590 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Majdalani1">[89]</xref>
###xml 653 657 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Majdalani2">[90]</xref>
###xml 659 663 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-CastaniCornet1">[91]</xref>
###xml 733 737 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Gottesman1">[92]</xref>
###xml 788 793 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flhDC</italic>
###xml 838 842 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-FrancezCharlot1">[51]</xref>
###xml 881 885 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-TorresCabassa1">[93]</xref>
###xml 905 908 902 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lon</italic>
###xml 1080 1084 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rcsC</italic>
###xml 1088 1092 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rcsD</italic>
###xml 1118 1122 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Majdalani2">[90]</xref>
###xml 1124 1128 1121 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Majdalani3">[94]</xref>
###xml 1144 1148 1141 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdoG</italic>
###xml 1153 1157 1150 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdoH</italic>
###xml 1284 1288 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
###xml 1316 1320 1313 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdoG</italic>
###xml 1322 1326 1319 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">modH</italic>
###xml 1332 1336 1329 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rcsC</italic>
###xml 1382 1390 1376 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g007">Figure 7</xref>
(A) The heatmaps shows loci whose disruption changed susceptibility to all three beta-lactams tested (See Materials and Methods). Hierarchical clustering was used to order both genes and drugs [84]. Table S2 lists the genes with annotations. (B) Both transposon insertions that disrupt genes that encode flagella components as well as insertions that indirectly reduce flagella synthesis by activating the Rcs system are beneficial. The core components of the Rcs system are RcsC, a hybrid sensor kinase, RcsD, a histidine phosphotransferase, and RcsB, a DNA-binding response regulator [89]. Other components are RcsF, a lipoprotein that activates RcsC [90], [91], and RcsA, a transcription factor that forms a heterodimer with RcsB [92]. Together, RcsA and RcsB repress transcription of flhDC, the master regulator of flagella synthesis [51]. RcsA is a target of the Lon protease [93], and insertions in lon, which stabilize RcsA, are beneficial. RcsC and RcsD both transfer phosphate to as well as remove phosphate from RcsB, resulting in higher activation of the Rcs system in rcsC or rcsD mutants than in wildtype [90], [94]. Insertions in mdoG and mdoH, which encode proteins that synthesize osmoregulated periplasmic glucans (OPGs), reduce motility by activating the Rcs system [25]. The beneficial effects of mdoG, modH, and rcsC disruptions are not limited to beta-lactams (Figure 7).
###end p 39
###begin title 40
Genetic and chemical perturbations of the folate biosynthesis pathway.
###end title 40
###begin p 41
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Patel1">[95]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Cayley1">[56]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Giladi1">[58]</xref>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folX</italic>
Sulfamonomethoxine inhibits FolP, a dihydropteroate synthase [95]; trimethoprim inhibits FolA, the cell's main dihydrofolate reductase (DHFR) [56]. FolM, which also acts as a DHFR, is not inhibited by trimethoprim [58]. Mutants lacking folM or folX are less sensitive to both to trimethoprim and sulfamonomethoxine.
###end p 41
###begin title 42
Mutations Beneficial in the Presence of Aminoglycosides
###end title 42
###begin p 43
###xml 183 192 183 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g004">Figure 4A</xref>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Verklin1">[32]</xref>
###xml 511 514 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 552 554 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 579 581 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 617 619 617 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 667 669 667 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 776 779 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kohanski1">[33]</xref>
###xml 1084 1093 1084 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g004">Figure 4B</xref>
###xml 1112 1116 1112 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kohanski2">[34]</xref>
###xml 1137 1144 1137 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1254 1258 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Schurek1">[22]</xref>
###xml 1281 1303 1281 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 1137 1144 <span type="species:ncbi:562">E. coli</span>
###xml 1281 1303 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Excluding loci with a general effect on antibiotic tolerance, disruptions of 73 loci were beneficial in all four aminoglycosides tested while disruptions of 14 loci were deleterious (Figure 4A). Using an aerobic environment - a condition where many antibiotics, especially aminoglycosides, are particularly effective [32] - likely increased the number and types of beneficial mutations identified. The set of beneficial disruption loci is enriched for genes with products involved in quinone binding (p = 1.7x10-15), ubiquinone biosynthesis (p = 1.1x10-5), glycolysis (p = 1.5x10-7), L-serine biosynthesis (p = 1.2x10-3), and cytochrome-c oxidase activity (p = 1.2x10-3). Additionally, the set is enriched for genes down-regulated in response to oxygen depravation (p = 3.5x10-16). Forty-eight of the beneficial mutations likely reduce the number of harmful hydroxyl radicals created by the Fenton reaction, part of a death-inducing chain reaction triggered by bactericidal antibiotics that includes NADH depletion, superoxide generation, and iron-sulfur center destabilization [33] (Figure 4B). Kohanski et al. [34] found that a set of E. coli strains with similar mutations had increased growth in the presence of gentamycin. Similarly, Schurek et al. [22] found that mutants of Pseudomonas aeruginosa with disruptions in homologous genes had increased tobramycin resistance
###end p 43
###begin p 44
###xml 68 77 68 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nuoG::kan</italic>
###xml 122 131 122 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nuoG::kan</italic>
###xml 267 275 267 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 295 304 295 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nuoG::kan</italic>
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s017">Table S5</xref>
To understand the magnitude of the tolerance changes, we competed a nuoG::kan strain with the wild-type strain. While the nuoG::kan strain was at a slight disadvantage in the media without drugs, in the presence of amikacin, the mutant rapidly took over the culture (Figure 2). In contrast, the nuoG::kan strain and other mutants that perturbed the pathway leading to death from Fenton reaction-derived hydroxyl radicals had at most modest (less than 3-fold) increases in MICs and frequently failed to exhibit any increase in MIC (Table S5). Since oxidative respiration processes are more active in the shaken cultures used for the competitions than in static MIC-measurement plates, the fitness effect of removing genes that contribute to the Fenton pathway likely depends strongly on the oxygen level.
###end p 44
###begin p 45
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kohanski1">[33]</xref>
Disruptions expected to interfere with the death pathway mediated by the Fenton reaction were widely beneficial only in selections with aminoglycosides, even though all bactericidal antibiotics are thought to trigger the pathway [33]. Furthermore, since the selections were performed at antibiotic concentrations that reduced, but did not completely inhibit, the wild-type strain's growth, observing genetic interactions with a putative death process was initially puzzling.
###end p 45
###begin p 46
###xml 290 299 290 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trpA::kan</italic>
###xml 378 387 378 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trpA::kan</italic>
###xml 480 488 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 496 505 496 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trpA::kan</italic>
###xml 578 587 578 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trpA::kan</italic>
###xml 642 650 642 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 764 773 764 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trpA::kan</italic>
An explanation for the apparent paradox came from the observation that during the enrichments in amikacin and streptomycin, disruptions in tryptophan biosynthesis genes that should have been lethal in the growth media, which lacked tryptophan, were strongly beneficial. We confirmed that a trpA::kan mutant does not grow in the media, with or without antibiotics, and that when trpA::kan and wild-type strains compete without antibiotics, the wild-type strain rapidly takes over (Figure 2). When trpA::kan and wild-type strains compete in the presence of amikacin, however, the trpA::kan strain remains an appreciable part of the population (Figure 2). Presumably, a portion of the wild-type cells are dying, lysing, and releasing enough tryptophan to support the trpA::kan mutant. Thus, in the aminoglycoside enrichments, although the overall population was growing, individual cells were dying. The existence of similar concentration regimes for other bactericidal drugs remains an interesting area for future inquiry.
###end p 46
###begin p 47
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Taber1">[35]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Holtje1">[36]</xref>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyaA</italic>
###xml 547 550 547 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crp</italic>
###xml 611 620 611 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyaA::kan</italic>
###xml 708 716 708 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s017">Table S5</xref>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crp</italic>
###xml 743 751 743 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g004">Figure 4</xref>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyaA</italic>
###xml 817 825 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g004">Figure 4</xref>
###xml 901 905 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ptsH</italic>
###xml 907 911 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ptsI</italic>
###xml 917 920 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crr</italic>
###xml 962 966 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Plumbridge1">[37]</xref>
###xml 1117 1121 1117 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Deutscher1">[38]</xref>
###xml 1208 1218 1208 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 1242 1246 1242 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyaA</italic>
###xml 1250 1253 1250 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crp</italic>
###xml 1304 1308 1304 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Alper1">[39]</xref>
Several beneficial disruptions that likely reduce NADH accumulation and lower the metabolic flux through the Fenton reaction may also provide secondary benefits. First, disruption of electron transport reduces the uptake of aminoglycosides [35]. Second, mutations that keep cAMP-CRP (cyclic AMP bound to the CRP transcription factor) levels low reduce the transcription of the cAMP-CRP regulon, which has been suggested to include transporters with affinity for aminoglycosides [36]. Disruptions of both cyaA, which encodes adenylate cyclase, and crp were beneficial during the aminoglycoside selections, and a cyaA::kan mutant has a higher MIC than the wildtype in three of the four aminoglycosides tested (Table S5). (crp does not appear in Figure 4 due to lack of data in gentamycin and tobramycin; cyaA is not in Figure 4 because its deletion was generally advantageous.) Transposon insertions in ptsH, ptsI, and crr, which are expected to lower cAMP levels [37], were also advantageous. Additionally, synthesis of the large cAMP-CRP regulon, which is expected to occur when the glucose in the media is exhausted [38], may not be the optimal allocation of cellular resources during antibiotic challenge. Salmonella strains lacking either cyaA or crp are more resistant to a wide range of antibiotics [39], suggesting that similar phenomena may occur with other organisms and antibiotics.
###end p 47
###begin p 48
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Srivatsan1">[40]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kuroda1">[41]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Jishage1">[42]</xref>
###xml 593 596 593 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gpp</italic>
###xml 600 604 600 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spoT</italic>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Cashel1">[43]</xref>
###xml 716 724 716 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g004">Figure 4</xref>
###xml 729 737 729 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s017">Table S5</xref>
###xml 767 770 767 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ppk</italic>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Akiyama1">[44]</xref>
###xml 816 819 816 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lon</italic>
###xml 853 861 853 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s018">Table S6</xref>
###xml 105 112 <span type="species:ncbi:562">E. coli</span>
Other beneficial disruptions seem to alter the timing and magnitude of the stringent response, a program E. coli uses to redirect energy from rRNA and tRNA transcription to the creation of amino acid biosynthesis enzymes in response to amino acid starvation [40]. To accomplish the transition, Lon protease bound to polyphosphate degrades ribosomal proteins, freeing amino acids that can be incorporated into the needed enzymes [41], and guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) bind RNA polymerase, altering promoter selectivity [42]. Transposon insertions near gpp or spoT, genes whose products affect the levels and ratio of ppGpp and pppGpp [43], are beneficial in aminoglycosides (Figure 4 and Table S5). Similarly, insertions near ppk, which encodes polyphosphate kinase [44], or lon are beneficial in tetracyclines (Table S6).
###end p 48
###begin p 49
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cpxA</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cpxP</italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Ruiz1">[45]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Ruiz1">[45]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Kohanski2">[34]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Wolfe1">[46]</xref>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Rainwater1">[47]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Newman1">[48]</xref>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Hirakawa1">[49]</xref>
###xml 105 112 <span type="species:ncbi:562">E. coli</span>
The advantageous character of cpxA and cpxP disruptions points to a role for the Cpx system, which helps E. coli respond to extracytoplasmic stress [45], in aminoglycoside susceptibility. At the core of the Cpx system are the CpxA histidine kinase, its cognate response regulator, CpxR, and CpxP, a periplasmic repressor of CpxA [45]. Recent work indicates that the presence of the wild-type Cpx system increases the number of hydroxyl radicals, the final output of the Fenton reaction death pathway, possibly through crosstalk with the Arc system [34]. Somewhat surprisingly, however, in the absence of CpxA, the cellular pool of CpxR is partially phosphorylated, and the Cpx pathway is active, not off [46]. Furthermore, some mutations that constitutively activate the Cpx system cause pleiotrophic effects including amikacin [47] and kanamycin resistance [48], possibly through the increased expression of drug efflux pumps [49]. Different levels of Cpx-Arc crosstalk between the various mutant and wild-type strains may account for these observations.
###end p 49
###begin title 50
Mutations Affecting Susceptibility to beta-lactams
###end title 50
###begin p 51
###xml 178 187 175 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g005">Figure 5A</xref>
###xml 260 269 257 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g005">Figure 5B</xref>
###xml 297 301 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Laubacher1">[50]</xref>
###xml 483 487 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Laubacher1">[50]</xref>
###xml 600 604 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-FrancezCharlot1">[51]</xref>
Excluding loci with a general effect on antibiotic tolerance, disruption of 33 loci was beneficial in all three beta-lactams tested, while disruption of 12 loci was deleterious (Figure 5A). Many of the beneficial disruptions turn on the Rcs signaling pathway (Figure 5B), which Laubacher and Ades [50] previously found to contribute to beta-lactam tolerance. Laubacher and Ades also showed that the tolerance is not dependent on the Rcs system's role in increasing capsule synthesis [50]; they did not, however, evaluate the importance of the system's function in suppressing flagella-based motility [51]. Since many other disruptions beneficial in beta-lactams are in genes whose products participate in flagella assembly, we hypothesize that suppression of flagella synthesis is responsible for the beneficial effect of Rcs system activation.
###end p 51
###begin p 52
###xml 91 100 88 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fliN::kan</italic>
###xml 293 297 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Macnab1">[52]</xref>
###xml 299 307 296 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 366 374 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 538 542 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Nambu1">[53]</xref>
###xml 688 697 682 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">filN::kan</italic>
To confirm that the lack of flagella confers an advantage in beta-lactams, we focused on a fliN::kan mutant in the presence of ampicillin. In direct competition with the parental strain, the mutant has a small advantage in media without drug, likely due to the high energetic cost of motility [52] (Figure 2). With ampicillin, however, the advantage is much larger (Figure 2), possibly because energy is a more valuable commodity in antibiotic-stressed cells. Alternatively, since assembling a flagellum requires peptidoglycan hydrolysis [53] and beta-lactams inhibit peptidoglycan transpeptidation, the combination of stresses may interact synergistically. Interestingly, the MIC of the filN::kan mutant as well as that of several other strains with increased fitness in ampicillin is within measurement error of that of the wild-type strain (data not shown), highlighting the ability of the selection method employed to identify mutations of small effect.
###end p 52
###begin p 53
###xml 124 133 121 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g005">Figure 5A</xref>
###xml 164 168 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mltB</italic>
###xml 172 175 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">slt</italic>
###xml 236 240 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-vonRechenberg1">[54]</xref>
###xml 273 277 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampG</italic>
###xml 336 340 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Jacobs1">[55]</xref>
###xml 348 352 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ampC</italic>
###xml 404 408 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Jacobs1">[55]</xref>
Disruptions expected to work synergistically with beta-lactams to disrupt peptidoglycan integrity are particularly harmful (Figure 5A). For example, loss of either mltB or slt, which encode membrane-bound lytic murein transglycosylases [54], is deleterious. Disruptions of ampG, which encodes a transporter involved in recycling murein [55], or of ampC, which encodes a beta-lactamase resistance protein [55], are also detrimental.
###end p 53
###begin title 54
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folX</italic>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM</italic>
Disruption of folX or folM is Beneficial in Drugs that Inhibit Folate Biosynthesis
###end title 54
###begin p 55
###xml 147 155 147 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g006">Figure 6</xref>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM</italic>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Cayley1">[56]</xref>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folA</italic>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thyA</italic>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Herrington1">[57]</xref>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM</italic>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Giladi1">[58]</xref>
###xml 534 543 534 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM::kan</italic>
###xml 673 681 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s014">Table S2</xref>
###xml 750 759 750 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM::kan</italic>
###xml 834 843 834 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM::kan</italic>
###xml 925 933 925 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 1230 1234 1230 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM</italic>
###xml 1311 1315 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM</italic>
###xml 1432 1439 1432 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 189 196 <span type="species:ncbi:562">E. coli</span>
###xml 237 244 <span type="species:ncbi:562">E. coli</span>
###xml 1432 1439 <span type="species:ncbi:562">E. coli</span>
The only locus whose disruption was beneficial in both sulfamonomethoxine and trimethoprim, two drugs that inhibit key steps in folate metabolism (Figure 6), was folM, which encodes one of E. coli's two dihydrofolate reductases (DHFRs). E. coli's other DHFR, FolA, is inhibited by trimethoprim [56], and folA is essential in minimal media unless thyA is also knocked out and the media is supplemented with thymidine [57]. In contrast, folM deletion strains have no major growth defects, and trimethoprim does not inhibit FolM [58]. A folM::kan mutant has a 5-fold higher MIC in sulfamonomethoxine than the wild-type strain, but no detectable change in MIC in trimethoprim (Table S2). To assess the strain's fitness more sensitively, we subjected the folM::kan strain to direct competition with the wild-type strain and found that the folM::kan mutation is neutral without drug and beneficial in the presence of trimethoprim (Figure 2). That the effects in sulfamonomethoxine are stronger than those in trimethoprim is consistent with the original transposon enrichment experiments, which needed two and four days to find loci affecting susceptibility to sulfamonomethoxine and trimethoprim, respectively. The beneficial nature of folM deletions in sulfamonomethoxine and trimethoprim is surprising, as deleting folM would naively be expected to reduce the available amount of DHFR, making a bad situation worse. We hypothesize that E. coli may respond to a lack of FolM by increasing FolA levels, ameliorating the effects of sulfamonomethoxine and trimethoprim.
###end p 55
###begin p 56
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folX</italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folX</italic>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folX</italic>
###xml 308 316 296 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s014">Table S2</xref>
###xml 324 328 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folM</italic>
###xml 332 336 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folX</italic>
###xml 484 492 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 596 600 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Haussmann1">[59]</xref>
###xml 697 705 685 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g006">Figure 6</xref>
###xml 714 718 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folX</italic>
###xml 765 769 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Hartl1">[60]</xref>
###xml 969 973 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Then1">[61]</xref>
Another gene connected to folate biosynthesis whose disruption was beneficial during the trimethoprim enrichment is folX. Although the folX data slightly missed the significance thresholds for the sulfamonomethoxine enrichment, deleting folX gave a approximately2-fold increase in MIC in sulfamonomethoxine (Table S2). Like folM, a folX deletion did not change the MIC in trimethoprim, but the mutant strain did have a competitive advantage over the wild-type strain in trimethoprim (Figure 2). FolX catalyzes the conversion of 7,8-dihydroneopterin triphosphate to dihydromonapterin-triphosphate [59], which redirects 7,8-dihydroneopterin triphosphate away from the synthesis of tetrahydrofolate (Figure 6). Thus, folX mutations likely allow metabolic compensation [60] by increasing the flux of metabolites through the folate biosynthesis pathway. In fact, increased flux from enhanced p-aminobenzoate production is a common mechanism of sulfamonomethoxine resistance [61].
###end p 56
###begin title 57
Loci Conferring a General Increase or Decrease in Antibiotic Susceptibility
###end title 57
###begin p 58
###xml 136 144 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g007">Figure 7</xref>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Thanassi1">[62]</xref>
Transposon insertions in or near 30 genes provided a significant change in fitness in at least three antibiotics with distinct targets (Figure 7). While some drugs of the same class, such as the aminoglycosides have similar fitness profiles, a mutant's behavior in the presence of a drug cannot generally be determined based solely on knowledge of the drug's mechanism of action. This is especially true for drugs of the same class, such as tetracycline and doxycycline, which have distinct chemical properties that restrict them to different routes of entry into the cell. In particular, the comparatively hydrophilic tetracycline passes through OmpF porins while the more hydrophobic doxycycline diffuses through the outer membrane [62].
###end p 58
###begin title 59
Genes altering susceptibility to three or more classes of antibiotics.
###end title 59
###begin p 60
###xml 435 456 435 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Black indicates no significant effect; gray indicates missing data. Antibiotics with the same target are written in the same color. Sulfamonomethoxine and trimethoprim inhibit different enzymes in the folic acid biosynthesis pathway; placing them in separate classes did not alter the results. Z-scores were calculated as described in Materials and Methods.
###end p 60
###begin p 61
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Hancock1">[63]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Mannel1">[64]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Hancock1">[63]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Barua1">[65]</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Tamae1">[20]</xref>
###xml 790 794 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rffA</italic>
###xml 869 878 869 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wzxE::kan</italic>
###xml 895 904 895 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rfaG::kan</italic>
###xml 1021 1029 1021 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s019">Table S7</xref>
###xml 1098 1102 1094 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wzxE</italic>
###xml 1198 1206 1194 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli generates multiple barriers to protect itself from different classes of harmful, foreign compounds, and we found, as expected, that many of the loci responsible for general alterations in susceptibility encode enzymes that synthesize cell envelope components. In particular, perturbations to the negatively-charged lipopolysaccharides (LPS) and enterobacteria common antigen (ECA) that protect the outer membrane [63], [64] were widely deleterious. Defective LPS is known to increase sensitivity to hydrophobic antibiotics and polycationic compounds such as aminoglycosides [63]. ECA, on the other hand, is thought to provide protection against organic acids [65], but its role in antibiotic tolerance had not been well explored; Tamae et al. [20] did, however, report that loss of rffA increases susceptibility to gentamycin. Strains with defective ECA (i.e., wzxE::kan) and LPS (i.e., rfaG::kan) generally had lower MICs than wild-type in the same antibiotics in which they were depleted during the selections (Table S7). Direct competitions with a wild-type strain confirmed that a DeltawzxE mutation is neutral in media without drug and deleterious in both nalidixic acid and amikacin (Figure 2).
###end p 61
###begin p 62
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yrbB</italic>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yrbE,</italic>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Malinverni1">[66]</xref>
###xml 300 309 300 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yrbE::kan</italic>
###xml 513 521 513 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s019">Table S7</xref>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Thanassi1">[62]</xref>
###xml 1091 1098 1091 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1205 1209 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Froelich1">[67]</xref>
###xml 1091 1098 <span type="species:ncbi:562">E. coli</span>
Rarely was the disruption of a locus beneficial in the presence of some drugs and deleterious in others. Notable exceptions are yrbB and yrbE, whose products belong to a system that prevents mislocalized phospholipids from accumulating in the outer membrane's outer leaflet [66]. We confirmed that a yrbE::kan strain has a higher MIC than the wildtype in bleomycin, has similar tolerance to the wildtype in tetracycline, and is more susceptible than the wildtype to nalidixic acid, lomefloxacin, and doxycycline (Table S7). Loss of the Yrb system likely has little effect in tetracycline because tetracycline enters the cell using porins rather than passing directly through the outer membrane [62]. Defects in the Yrb system likely reduce the negative charge on the outer membrane, which would decrease the permeability to positively charged bleomycin and increase the permeability towards the more neutral and negatively charged nalidixic acid, lomefloxacin, and doxycycline. The mechanism may be similar to how expression of the PmrA regulon, which makes the LPS less negative, increases E. coli's tolerance to the positively charged polymyxin B but also increases susceptibility to anionic detergents [67].
###end p 62
###begin p 63
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Lewis1">[68]</xref>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</italic>
###xml 300 307 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Okusu1">[69]</xref>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acrB</italic>
###xml 431 439 431 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g007">Figure 7</xref>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phoP</italic>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rob</italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acrAB</italic>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Minagawa1">[70]</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Rosenberg1">[71]</xref>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acrR</italic>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acrAB</italic>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Ma1">[72]</xref>
###xml 300 307 <span type="species:ncbi:562">E. coli</span>
To increase antibiotic tolerance, bacteria often reduce the intracellular drug concentration by increasing the expression of efflux pumps that use either ATP or membrane potential to expel toxic agents [68]. Not surprisingly, disruption of genes that control the levels of the AcrB/AcrA/TolC system, E. coli's main drug efflux pump [69], alters tolerance to multiple antibiotics. Disruption of the acrB gene is widely deleterious (Figure 7). Disruptions of phoP or rob, which encode transcriptional activators of the acrAB operon [70], [71], are also deleterious, while disruption of acrR, which encodes a transcriptional repressor of the acrAB operon [72], is beneficial. Disruption of no other drug pump was generally deleterious.
###end p 63
###begin p 64
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Harms1">[73]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Schlsser1">[74]</xref>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sapD</italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trkA</italic>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trkH</italic>
###xml 367 375 367 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g007">Figure 7</xref>
###xml 390 399 390 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sapD::kan</italic>
###xml 530 538 530 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s019">Table S7</xref>
###xml 579 583 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sapD</italic>
###xml 625 629 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sapD</italic>
###xml 765 773 757 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g002">Figure 2</xref>
###xml 14 21 <span type="species:ncbi:562">E. coli</span>
Disruption of E. coli's Trk potassium transport system was beneficial in a wide range of antibiotics. The low-affinity transporter contains TrkA, TrkE (SapD), and either TrkH or TrkG proteins [73], [74], and the Tn-enrichment experiment indicated that disruptions in sapD, trkA, and trkH are beneficial in piperacillin, doxycycline, tetracycline, and nalidixic acid (Figure 7). Work with a sapD::kan mutant indicated that removal of the system increases the MIC by about 1.5-fold in doxycycline, tetracycline, and nalidixic acid (Table S7). In direct competitions between a DeltasapD mutant and the parental strain, the DeltasapD mutation was slightly deleterious in the absence of drug, beneficial in the presence of nalidixic acid, and neutral with tetracycline (Figure 2). The connection between potassium transport and antibiotic tolerance merits further study.
###end p 64
###begin p 65
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yecR</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yfgC</italic>
###xml 87 95 87 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g007">Figure 7</xref>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Tamae1">[20]</xref>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yfgC</italic>
###xml 347 355 347 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s019">Table S7</xref>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yfgC</italic>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Gardy1">[75]</xref>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yecR</italic>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Stafford1">[76]</xref>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yecR</italic>
###xml 573 585 573 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacter</italic>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yfgC</italic>
Notably, disruptions of two genes of unknown function, yecR and yfgC, are deleterious (Figure 7). Tamae et al. [20] found that removal of yfgC decreases the MIC in vancomycin, rifampicin, and ampicillin. We confirmed the result for ampicillin, and we found that the MIC is also lower than wild-type in fusidic acid, doxycycline, and trimethoprim (Table S7). yfgC has homology to peptidases, and PSORTb [75] predicts that the protein is in the inner membrane. yecR is regulated by FlhDC [76] and has homology to lipoproteins. Strong homologs to yecR are found only in other Enterobacter species; homologs for yfgC are slightly more widespread, appearing in multiple gamma-proteobacteria.
###end p 65
###begin title 66
Resistance through Accumulation of Mutations of Small Effect
###end title 66
###begin p 67
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 502 511 502 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ybjC::kan</italic>
###xml 516 525 516 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ompR::kan</italic>
###xml 620 634 616 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ompR ybjC::kan</italic>
###xml 705 714 701 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ybjC::kan</italic>
###xml 797 801 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nfsA</italic>
###xml 913 917 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Whiteway1">[77]</xref>
###xml 938 947 934 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sapD::kan</italic>
###xml 952 960 948 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lon::kan</italic>
###xml 1054 1067 1046 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sapD lon::kan</italic>
###xml 29 36 <span type="species:ncbi:562">E. coli</span>
To explore the potential for E. coli to acquire higher levels of antibiotic tolerance through the sequential accumulation of the identified chromosomal mutations, we constructed several double mutants. For each of two drugs, from among the genes that gave measurable MIC increases when removed singly, we chose pairs that were putatively in different pathways. As expected, the double mutants exhibited higher MICs than the parental strain and both of the two single mutant derivatives. In particular, ybjC::kan and ompR::kan mutants have MICs 2.25-fold greater than the wild-type strain in nitrofurantoin, while a DeltaompR ybjC::kan double mutant has a MIC 5-fold greater than the wild-type strain. The ybjC::kan allele's beneficial effects likely come from reduced expression of the downstream nfsA gene, which encodes an oxygen-insensitive nitroreductase that converts nitrofurantoin into toxic intermediates [77]. Similarly, MICs of sapD::kan and lon::kan mutants in tetracycline are 1.5-fold higher than the wild-type strain, and the MIC of a DeltasapD lon::kan mutant is 2.25-fold greater than the wild-type parent.
###end p 67
###begin p 68
###xml 270 277 270 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 396 405 396 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Mwangi1">[78]</xref>
###xml 615 628 615 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-ElGarch1">[24]</xref>
###xml 637 656 637 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 656 660 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Albert1">[23]</xref>
###xml 270 277 <span type="species:ncbi:562">E. coli</span>
###xml 396 405 <span type="species:ncbi:1280">S. aureus</span>
###xml 615 628 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 637 656 <span type="species:ncbi:210">Helicobacter pylori</span>
A wide variety of mutations, including single base pair changes, can cause the null phenotypes attained in this work through transposon insertions and gene replacements. Furthermore, for most antibiotics, the set of beneficial disruptions spans multiple pathways. Thus, E. coli's current genome is likely mutationally close to one conferring significantly higher antibiotic tolerance. A clinical S. aureus strain was observed acquiring 35 chromosomal mutations on the way to vancomycin resistance [78], and in the laboratory, multiple weak chromosomal mutations have been combined to give higher resistance in both P. aeruginosa[24] and Helicobacter pylori[23], suggesting that the phenomenon is quite general.
###end p 68
###begin title 69
Concluding Remarks
###end title 69
###begin p 70
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 371 378 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 68 75 <span type="species:ncbi:562">E. coli</span>
###xml 371 378 <span type="species:ncbi:562">E. coli</span>
In this work, we competitively grew transposon insertion mutants of E. coli in batch cultures with drug concentrations that had a moderate impact on the parental strain's growth rate. Propagating the mutant collection for a sufficiently long duration allowed us to identify both beneficial and deleterious mutations of a wide range of strengths. Our analyses reveal that E. coli has a large mutational target size for altering its antibiotic tolerance.
###end p 70
###begin p 71
As the disruption of the genes identified in this study pushes cells from the growth regime of moderate inhibition towards one of the extremes of no inhibition or full inhibition, the products of the loci and the pathways in which they reside are promising starting points for the development of adjuvant therapies. For example, if a gene's deletion causes hypersensitivity to an antibiotic, that antibiotic and a drug targeting the corresponding gene product may act synergistically. Similarly, when disrupting a pathway increases bacterial fitness in the presence of a particular antibiotic, stimulating the pathway might enhance the antibiotic's efficacy. The development of such adjuvant therapies has the potential to expand the usefulness of the limited set of antibiotics currently available.
###end p 71
###begin p 72
###xml 665 672 665 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 665 672 <span type="species:ncbi:562">E. coli</span>
With whole-genome sequencing becoming increasingly affordable, this work should provide a wealth of data for interpreting mutations present in drug resistant, pathogenic strains. As approximately half of the genes identified as altering fitness in the presence of antibiotics increase tolerance when disrupted, it will be important to learn how frequently and in what combinations the adaptive building blocks revealed here appear in clinical and environmental settings. The bulk of the loci identified occur in multiple species, and future work will be needed to discover how specific the beneficial and deleterious nature of each perturbation is to the wiring of E. coli's cellular network. Our observations should provide a scaffold for understanding the contribution of chromosomal mutations to antibiotic resistance as well as an aid in the development of novel therapeutics.
###end p 72
###begin title 73
Materials and Methods
###end title 73
###begin title 74
Bacterial Strains and Growth Conditions
###end title 74
###begin p 75
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Blattner1">[79]</xref>
###xml 119 123 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 164 168 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
###xml 213 217 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Ausubel1">[80]</xref>
###xml 280 281 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 294 295 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 37 44 <span type="species:ncbi:562">E. coli</span>
###xml 365 370 <span type="species:ncbi:4932">yeast</span>
All experiments were performed using E. coli MG1655 [79]. Transposon insertion mutants were generated in a MG1655 DeltalacZ strain as described in a previous study [25]. All experiments were conducted in M9 salts [80] supplemented with 0.4% glucose, 0.1% casamino acids, 1 mM MgSO4, 0.1 mM CaCl2, and 1.5 muM thiamine. LB media contained 0.1% Bacto Tryptone, 0.05% yeast extract, and 0.05% NaCl. All antibiotics were purchased from Sigma. Unless otherwise noted, cultures were shaken at 37degreesC.
###end p 75
###begin title 76
Transposon Library Enrichments, DNA manipulation, and Hybridization
###end title 76
###begin p 77
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005629-g001">Figure 1C</xref>
###xml 558 565 558 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005629-t001">Table 1</xref>
###xml 910 917 910 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005629-t001">Table 1</xref>
Genetic footprinting and subsequent hybridization to DNA spotted arrays were performed as described in Girgis et al. [25]. As a starting point, we hybridized DNA from the day in which minor banding patterns began to emerge (Figure 1C) and then adjusted the chosen day as necessary. On early days during a selection, a mutant's fitness did not have a measurable effect on its prevalence, while on very late days, only a few types of mutants remained, and the relative fitness of the mutants that completely dropped out could not be discerned. In a few cases (Table 1), data from adjacent days of roughly equal suitability were included in the analysis. Other hybridizations from days not ultimately chosen exhibited either extreme selection or little to no selection and were excluded. The distinct behavior of the library in each antibiotic necessitated the choice of different days for different antibiotics (Table 1). To reduce the chance of spontaneous mutations overtaking the cultures, to remove the need for additional sets of controls for comparison, and to focus on transposon insertions causing larger effects, no samples from days 5-7 were chosen. Samples from at least two independent replicate selections were hybridized for each antibiotic. As controls, six samples from independent selections in the absence of any drug were hybridized.
###end p 77
###begin title 78
Determining Significant Changes
###end title 78
###begin p 79
###xml 334 335 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 418 419 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 564 568 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Girgis1">[25]</xref>
Ratios (transposon signal/genomic DNA signal) from the antibiotic enrichments were compared to both the ratios from the original unselected library and to ratios from enrichments of the transposon library performed in identical media without antibiotics. Two z-scores were calculated for each ratio, r, where z = (x-mu)/sigma, x = log2(r), and mu and sigma are the mean and standard deviation, respectively, of the log2 ratios for the gene from reference hybridizations. One z-score used five reference hybridizations of the unselected library (from Girgis et al. [25]) and the other used six reference hybridizations of the library selected in the same media without antibiotics. All six no-antibiotic samples came from independent selections; three selections lasted two days, and three lasted four days.
###end p 79
###begin p 80
###xml 537 547 537 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s021">Dataset S2</xref>
###xml 595 605 595 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s022">Dataset S3</xref>
###xml 689 699 689 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s023">Dataset S4</xref>
###xml 721 731 721 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s024">Dataset S5</xref>
###xml 784 794 784 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s020">Dataset S1</xref>
To identify the most reproducible fitness effects, we considered all of the z-scores for each gene for a given antibiotic. (Antibiotics with two and three hybridizations had four and six z-scores, respectively.) When all of the z-scores had the same sign, we assigned the gene the z-score in the set that was closest to zero (representing the smallest effect). When a gene had z-scores of different signs, the gene was assigned a score of 0, indicating no consistent fitness effect. Supplementary information contains normalized ratios (Dataset S2), z-scores relative to the unselected library (Dataset S3), z-scores relative to the enrichments performed in the media without antibiotics (Dataset S4), combined z-scores (Dataset S5), and the combined z-scores considered significant (Dataset S1).
###end p 80
###begin p 81
###xml 220 227 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s001">Text S1</xref>
The significance threshold was set so that two false positives are expected per antibiotic. False positives were estimated by treating randomly chosen reference samples as data and repeating the analysis procedure. (See Text S1.)
###end p 81
###begin title 82
Determining Genes Common to Aminoglycosides and beta-lactams
###end title 82
###begin p 83
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 421 423 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii</italic>
In identifying loci important to fitness in specific antibiotic classes, care was taken to prevent the exclusion of genes that barely missed the significance cutoff for a subset of the drugs. As such, a locus was considered to be beneficial or deleterious in aminoglycosides if i) the prevalence of mutants where the locus was disrupted changed significantly during the enrichments for at least two of the four drugs and ii) the z-scores for the locus for all four drugs had the same sign. For example, disruption of a locus was classified as beneficial in aminoglycosides if the gene had positive z-scores in all four drugs, and the z-scores reached the significance level for at least two drugs. beta-lactams were treated similarly except that the disruption of a locus was required to cause a significant fitness change during the enrichments for at least one of three drugs. Loci with a general effect on antibiotic tolerance were excluded from the sets.
###end p 83
###begin title 84
Strain Construction
###end title 84
###begin p 85
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kan</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P1vir</italic>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Silhavy1">[81]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Baba1">[82]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Blattner1">[79]</xref>
###xml 496 499 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kan</italic>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Datsenko1">[83]</xref>
Rather than choosing one of the many mutants in the library with a transposon inserted in a particular gene, we corroborated behavior observed during the selections using strains where the gene of interest had either been replaced with a kanamycin (kan) resistance cassette or removed to create an in-frame deletion. To construct the strains, P1vir transduction [81] was used to move the necessary alleles from the Keio collection [82] to MG1655 [79]. To create unmarked, in-frame deletions, the kan cassette was removed using FLP recombinase [83]. In rare cases, both the original transposon insertions as well as the kanamycin resistance cassette can produce polar effects, resulting in mutants with phenotypes distinct from the null phenotype of the disrupted or replaced gene.
###end p 85
###begin title 86
Software Used
###end title 86
###begin p 87
###xml 32 36 32 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Eisen1">[84]</xref>
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Eisen1">[84]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Karp1">[85]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Lee1">[86]</xref>
Data was clustered with Cluster [84] and visualized using Treeview [84]. Data manipulations were performed using Perl and Matlab. iPAGE (Hani Goodarzi, unpublished data) was used to examine sets of genes for enrichments in GO category, transcription factor regulon, and stress response membership. Annotations came from EcoCyc [85] and genome-tools [86].
###end p 87
###begin title 88
Supporting Information
###end title 88
###begin p 89
###xml 11 32 11 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Additional Materials and Methods
###end p 89
###begin p 90
(0.07 MB PDF)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
Dose Response Curves Used to Select Drug Concentrations. For each antibiotic, fresh media containing various drug concentrations was inoculated with overnight culture of the wild-type strain. Cultures were shaken at 37degreesC, and growth was monitored using OD600 readings. Blue indicates the concentrations chosen for the enrichments.
###end p 92
###begin p 93
(0.18 MB PDF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Levy1">[1]</xref>
Gel images from enrichments done in the study media in the absence of antibiotics. Shown are the amplified Tn-adjacent DNA from all seven days for each of the seven repetitions. DNA was amplified as described in Girgis et al. [1] and separated on a 2% agarose gel. Yellow rectangles indicate samples hybridized. From the bottom, marker sizes are 100, 200, 300, 400, 500, 650, 850, and 1000 bases.
###end p 95
###begin p 96
(1.48 MB PDF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
###xml 254 257 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005629-Levy1">[1]</xref>
Gel images from Tn-insertion library enrichments done in the presence of antibiotics. Shown are the amplified Tn-adjacent DNA from all seven days for each of the three repetitions done for each antibiotic. DNA was amplified as described in Girgis et al. [1] and separated on a 2% agarose gel. Yellow rectangles indicate samples hybridized. From the bottom, marker sizes are 100, 200, 300, 400, 500, 650, 850, and 1000 bases.
###end p 98
###begin p 99
(2.10 MB PDF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
###xml 245 266 245 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Loci whose disruption was significant in at least one quinolone. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Black indicates no significant effect. Z-scores were calculated as described in Materials and Methods.
###end p 101
###begin p 102
(0.21 MB PDF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
###xml 277 298 277 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Loci whose disruption was significant in at least one tetracycline. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Black indicates no significant effect; gray indicates missing data. Z-scores were calculated as described in Materials and Methods.
###end p 104
###begin p 105
(0.24 MB PDF)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
###xml 298 319 298 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Loci whose disruption was significant in at least one folic acid biosynthesis inhibitor. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Black indicates no significant effect; gray indicates missing data. Z-scores were calculated as described in Materials and Methods.
###end p 107
###begin p 108
(0.13 MB PDF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 280 301 280 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Loci whose disruption was significant in at least one inhibitor of the 50S subunit of the ribosome. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Black indicates no significant effect. Z-scores were calculated as described in Materials and Methods.
###end p 110
###begin p 111
(0.08 MB PDF)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
###xml 193 214 193 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
Loci whose disruption was significant in bleomycin. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Z-scores were calculated as described in Materials and Methods.
###end p 113
###begin p 114
(0.13 MB PDF)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
###xml 247 268 244 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 406 414 403 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s014">Table S2</xref>
Loci whose disruption was significant in at least one beta-lactam. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Black indicates no significant effect. Z-scores were calculated as described in Materials and Methods. Note that this set of loci is distinct from the set of loci whose disruption caused significant changes in all the beta-lactams tested (Table S2).
###end p 116
###begin p 117
(0.10 MB PDF)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin p 119
###xml 198 205 198 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Methods</xref>
Loci whose disruption was significant in nitrofurantoin. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Z-scores were calculated as described in Methods.
###end p 119
###begin p 120
(0.09 MB PDF)
###end p 120
###begin p 121
Click here for additional data file.
###end p 121
###begin p 122
###xml 213 223 213 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005629.s020">Dataset S1</xref>
Loci whose disruption was significant in at least one aminoglycoside. Due to the large size of the set, genes whose disruption was only significant in tobramycin are not shown. Data for tobramycin is available in Dataset S1. Yellow (blue) indicates that transposon insertions in or near a gene were beneficial (deleterious). Black indicates no significant effect; gray indicates missing data.
###end p 122
###begin p 123
(0.24 MB PDF)
###end p 123
###begin p 124
Click here for additional data file.
###end p 124
###begin p 125
Loci that changed susceptibility to all aminoglycosides tested.
###end p 125
###begin p 126
(0.08 MB PDF)
###end p 126
###begin p 127
Click here for additional data file.
###end p 127
###begin p 128
Loci that changed susceptibility to all beta-lactams tested.
###end p 128
###begin p 129
(0.07 MB PDF)
###end p 129
###begin p 130
Click here for additional data file.
###end p 130
###begin p 131
Genes identified in this work as having a general role in antibiotic susceptibility.
###end p 131
###begin p 132
(0.07 MB PDF)
###end p 132
###begin p 133
Click here for additional data file.
###end p 133
###begin p 134
Additional genes identified in both this study and previous work.
###end p 134
###begin p 135
(0.07 MB PDF)
###end p 135
###begin p 136
Click here for additional data file.
###end p 136
###begin p 137
MIC changes in aminoglycosides.
###end p 137
###begin p 138
(0.06 MB PDF)
###end p 138
###begin p 139
Click here for additional data file.
###end p 139
###begin p 140
Additional class-specific MIC changes (non-aminoglycosides).
###end p 140
###begin p 141
(0.07 MB PDF)
###end p 141
###begin p 142
Click here for additional data file.
###end p 142
###begin p 143
MIC changes for mutants with altered susceptibility to multiple drug classes.
###end p 143
###begin p 144
(0.07 MB PDF)
###end p 144
###begin p 145
Click here for additional data file.
###end p 145
###begin p 146
Z-scores for loci with a significant effect on antibiotic susceptibility.
###end p 146
###begin p 147
(0.90 MB XLS)
###end p 147
###begin p 148
Click here for additional data file.
###end p 148
###begin p 149
Normalized ratios (transposon signal/genomic DNA signal)
###end p 149
###begin p 150
(4.23 MB XLS)
###end p 150
###begin p 151
Click here for additional data file.
###end p 151
###begin p 152
Z-scores for individual hybridization computed relative to five hybridizations of the original, unselected library.
###end p 152
###begin p 153
(3.58 MB XLS)
###end p 153
###begin p 154
Click here for additional data file.
###end p 154
###begin p 155
Z-scores for individual hybridizations computed relative to six hybridization of the library cultured in the same media (M9 with glucose and casamino acids) without antibiotics.
###end p 155
###begin p 156
(3.58 MB XLS)
###end p 156
###begin p 157
Click here for additional data file.
###end p 157
###begin p 158
Combined z-scores for all loci.
###end p 158
###begin p 159
(1.24 MB XLS)
###end p 159
###begin p 160
Click here for additional data file.
###end p 160
###begin p 161
We thank members of the Tavazoie lab for critical reading of the manuscript and Hani Goodarzi for use of unpublished software. We thank Juliana C. Malinverni and Thomas J. Silhavy for helpful discussions and for sharing unpublished data.
###end p 161
###begin title 162
References
###end title 162
###begin article-title 163
Antibacterial resistance worldwide: causes, challenges and responses.
###end article-title 163
###begin article-title 164
Where will new antibiotics come from?
###end article-title 164
###begin article-title 165
Chemical warfare from an ecological perspective.
###end article-title 165
###begin article-title 166
Mutant selection window hypothesis updated.
###end article-title 166
###begin article-title 167
The world of subinhibitory antibiotic concentrations.
###end article-title 167
###begin article-title 168
Pharmacodynamics: relation to antimicrobial resistance.
###end article-title 168
###begin article-title 169
Sampling the antibiotic resistome.
###end article-title 169
###begin article-title 170
Antibiotics as signals that trigger specific bacterial responses.
###end article-title 170
###begin article-title 171
Pharmaceutical antibiotic compounds in soils - a review.
###end article-title 171
###begin article-title 172
Removal of antibiotics in conventional and advanced wastewater treatment: Implications for environmental discharge and wastewater recycling.
###end article-title 172
###begin article-title 173
Tylosin-resistant bacteria cultivated from agricultural soil.
###end article-title 173
###begin article-title 174
Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms.
###end article-title 174
###begin article-title 175
Microbial and viral drug resistance mechanisms.
###end article-title 175
###begin article-title 176
Molecular mechanisms that confer antibacterial drug resistance.
###end article-title 176
###begin article-title 177
Mechanisms of resistance to antibiotics.
###end article-title 177
###begin article-title 178
###xml 49 70 49 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 49 70 <span type="species:ncbi:1280">Staphylococcus aureus</span>
The molecular evolution of methicillin-resistant Staphylococcus aureus.
###end article-title 178
###begin article-title 179
Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
###end article-title 179
###begin article-title 180
###xml 53 73 53 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acinetobacter baylyi</italic>
###xml 53 73 <span type="species:ncbi:202950">Acinetobacter baylyi</span>
Genes involved in intrinsic antibiotic resistance of Acinetobacter baylyi.
###end article-title 180
###begin article-title 181
The neglected intrinsic resistome of bacterial pathogens.
###end article-title 181
###begin article-title 182
###xml 89 105 89 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 89 105 <span type="species:ncbi:562">Escherichia coli</span>
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
###end article-title 182
###begin article-title 183
###xml 56 78 56 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 56 78 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility.
###end article-title 183
###begin article-title 184
###xml 69 91 69 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 69 91 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
###end article-title 184
###begin article-title 185
###xml 69 88 69 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 69 88 <span type="species:ncbi:210">Helicobacter pylori</span>
Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori.
###end article-title 185
###begin article-title 186
###xml 75 97 75 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 75 97 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
###end article-title 186
###begin article-title 187
A comprehensive genetic characterization of bacterial motility.
###end article-title 187
###begin article-title 188
Low-level antibacterial resistance: a gateway to clinical resistance.
###end article-title 188
###begin article-title 189
Environmental stresses can alleviate the average deleterious effect of mutations.
###end article-title 189
###begin article-title 190
Pleiotropy, Natural Selection, and the Evolution of Senescence.
###end article-title 190
###begin article-title 191
Alteration of effectiveness of antibiotics by anaerobiosis.
###end article-title 191
###begin article-title 192
A common mechanism of cellular death induced by bactericidal antibiotics.
###end article-title 192
###begin article-title 193
Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death.
###end article-title 193
###begin article-title 194
Bacterial uptake of aminoglycoside antibiotics.
###end article-title 194
###begin article-title 195
###xml 67 83 67 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 67 83 <span type="species:ncbi:562">Escherichia coli</span>
Streptomycin uptake via an inducible polyamine transport system in Escherichia coli.
###end article-title 195
###begin article-title 196
###xml 44 60 44 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 44 60 <span type="species:ncbi:562">Escherichia coli</span>
Regulation of gene expression in the PTS in Escherichia coli: the role and interactions of Mlc.
###end article-title 196
###begin article-title 197
The mechanisms of carbon catabolite repression in bacteria.
###end article-title 197
###begin article-title 198
###xml 107 133 107 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella typhimurium cya</italic>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">crp</italic>
###xml 107 129 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants.
###end article-title 198
###begin article-title 199
Control of bacterial transcription, translation and replication by (p)ppGpp.
###end article-title 199
###begin article-title 200
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 98 105 <span type="species:ncbi:562">E. coli</span>
Role of inorganic polyphosphate in promoting ribosomal protein degradation by the Lon protease in E. coli.
###end article-title 200
###begin article-title 201
Regulation of sigma factor competition by the alarmone ppGpp.
###end article-title 201
###begin article-title 202
The stringent response.
###end article-title 202
###begin article-title 203
###xml 33 49 33 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ppk</italic>
###xml 33 49 <span type="species:ncbi:562">Escherichia coli</span>
The polyphosphate kinase gene of Escherichia coli. Isolation and sequence of the ppk gene and membrane location of the protein.
###end article-title 203
###begin article-title 204
###xml 42 58 42 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
Sensing external stress: watchdogs of the Escherichia coli cell envelope.
###end article-title 204
###begin article-title 205
Signal integration by the two-component signal transduction response regulator CpxR.
###end article-title 205
###begin article-title 206
###xml 20 36 20 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cpxA</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ecfB</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ssd</italic>
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eup</italic>
###xml 20 41 <span type="species:ncbi:83333">Escherichia coli K-12</span>
The Cpx proteins of Escherichia coli K-12: evidence that cpxA, ecfB, ssd, and eup mutations all identify the same gene.
###end article-title 206
###begin article-title 207
###xml 24 40 24 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ssd</italic>
###xml 24 45 <span type="species:ncbi:83333">Escherichia coli K-12</span>
L-serine degradation in Escherichia coli K-12: directly isolated ssd mutants and their intragenic revertants.
###end article-title 207
###begin article-title 208
###xml 139 155 139 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 139 155 <span type="species:ncbi:562">Escherichia coli</span>
Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli.
###end article-title 208
###begin article-title 209
The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance.
###end article-title 209
###begin article-title 210
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flhDC</italic>
###xml 76 92 76 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 76 92 <span type="species:ncbi:562">Escherichia coli</span>
RcsCDB His-Asp phosphorelay system negatively regulates the flhDC operon in Escherichia coli.
###end article-title 210
###begin article-title 211
Flagella and motility.
###end article-title 211
###begin article-title 212
###xml 97 119 97 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella typhimurium</italic>
###xml 97 119 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Peptidoglycan-hydrolyzing activity of the FlgJ protein, essential for flagellar rod formation in Salmonella typhimurium.
###end article-title 212
###begin article-title 213
Affinity chromatography as a means to study multienzyme complexes involved in murein synthesis.
###end article-title 213
###begin article-title 214
Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction.
###end article-title 214
###begin article-title 215
###xml 58 74 58 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 58 74 <span type="species:ncbi:562">Escherichia coli</span>
Kinetics of substrate, coenzyme, and inhibitor binding to Escherichia coli dihydrofolate reductase.
###end article-title 215
###begin article-title 216
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">folA</italic>
###xml 43 59 43 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 43 63 <span type="species:ncbi:83333">Escherichia coli K12</span>
Growth properties of a folA null mutant of Escherichia coli K12.
###end article-title 216
###begin article-title 217
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 61 77 <span type="species:ncbi:562">Escherichia coli</span>
FolM, a new chromosomally encoded dihydrofolate reductase in Escherichia coli.
###end article-title 217
###begin article-title 218
###xml 43 59 43 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 43 59 <span type="species:ncbi:562">Escherichia coli</span>
Dihydroneopterin triphosphate epimerase of Escherichia coli: purification, genetic cloning, and expression.
###end article-title 218
###begin article-title 219
###xml 27 43 27 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 27 43 <span type="species:ncbi:562">Escherichia coli</span>
The population genetics of Escherichia coli.
###end article-title 219
###begin article-title 220
Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole.
###end article-title 220
###begin article-title 221
###xml 77 93 77 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 77 93 <span type="species:ncbi:562">Escherichia coli</span>
Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli.
###end article-title 221
###begin article-title 222
Alterations in outer membrane permeability.
###end article-title 222
###begin article-title 223
Isolation and chemical characterization of the enterobacterial common antigen.
###end article-title 223
###begin article-title 224
###xml 95 111 95 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 95 119 <span type="species:ncbi:83334">Escherichia coli O157:H7</span>
Involvement of surface polysaccharides in the organic acid resistance of Shiga Toxin-producing Escherichia coli O157:H7.
###end article-title 224
###begin article-title 225
An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane.
###end article-title 225
###begin article-title 226
###xml 2 6 2 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pmrA</italic>
###xml 38 54 38 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 38 54 <span type="species:ncbi:562">Escherichia coli</span>
A pmrA constitutive mutant sensitizes Escherichia coli to deoxycholic acid.
###end article-title 226
###begin article-title 227
Multidrug resistance pumps in bacteria: variations on a theme.
###end article-title 227
###begin article-title 228
###xml 79 95 79 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 79 95 <span type="species:ncbi:562">Escherichia coli</span>
AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.
###end article-title 228
###begin article-title 229
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 70 86 70 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 70 86 <span type="species:ncbi:562">Escherichia coli</span>
Identification and molecular characterization of the Mg2+ stimulon of Escherichia coli.
###end article-title 229
###begin article-title 230
###xml 52 68 52 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 52 68 <span type="species:ncbi:562">Escherichia coli</span>
Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein.
###end article-title 230
###begin article-title 231
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acrAB</italic>
###xml 85 101 85 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 85 101 <span type="species:ncbi:562">Escherichia coli</span>
The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals.
###end article-title 231
###begin article-title 232
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</sup>
###xml 126 142 126 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 126 147 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Identification of the ABC protein SapD as the subunit that confers ATP dependence to the K+-uptake systems TrkH and TrkG from Escherichia coli K-12.
###end article-title 232
###begin article-title 233
###xml 108 124 108 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 108 124 <span type="species:ncbi:562">Escherichia coli</span>
TrkH and its homolog, TrkG, determine the specificity and kinetics of cation transport by the Trk system of Escherichia coli.
###end article-title 233
###begin article-title 234
PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis.
###end article-title 234
###begin article-title 235
###xml 69 85 69 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 69 85 <span type="species:ncbi:562">Escherichia coli</span>
Binding and transcriptional activation of non-flagellar genes by the Escherichia coli flagellar master regulator FlhD2C2.
###end article-title 235
###begin article-title 236
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nfsA</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nfsB</italic>
###xml 135 151 135 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 135 151 <span type="species:ncbi:562">Escherichia coli</span>
Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
###end article-title 236
###begin article-title 237
###xml 58 79 58 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 58 79 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.
###end article-title 237
###begin article-title 238
###xml 32 48 32 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 32 53 <span type="species:ncbi:83333">Escherichia coli K-12</span>
The complete genome sequence of Escherichia coli K-12.
###end article-title 238
###begin article-title 239
###xml 16 32 16 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 16 37 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection.
###end article-title 239
###begin article-title 240
###xml 46 62 46 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 46 67 <span type="species:ncbi:83333">Escherichia coli K-12</span>
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
###end article-title 240
###begin article-title 241
Cluster analysis and display of genome-wide expression patterns.
###end article-title 241
###begin article-title 242
###xml 35 51 35 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 35 56 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Multidimensional annotation of the Escherichia coli K-12 genome.
###end article-title 242
###begin article-title 243
Genome-tools: a flexible package for genome sequence analysis.
###end article-title 243
###begin article-title 244
###xml 36 52 36 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 36 52 <span type="species:ncbi:562">Escherichia coli</span>
Long-term experimental evolution in Escherichia coli. IV. Targets of selection and the specificity of adaptation.
###end article-title 244
###begin article-title 245
Structure, function, and formation of biological iron-sulfur clusters.
###end article-title 245
###begin article-title 246
The Rcs phosphorelay: a complex signal transduction system.
###end article-title 246
###begin article-title 247
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 61 77 <span type="species:ncbi:562">Escherichia coli</span>
Role of RcsF in signaling to the Rcs phosphorelay pathway in Escherichia coli.
###end article-title 247
###begin article-title 248
###xml 95 111 95 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 95 111 <span type="species:ncbi:562">Escherichia coli</span>
RcsF is an outer membrane lipoprotein involved in the RcsCDB phosphorelay signaling pathway in Escherichia coli.
###end article-title 248
###begin article-title 249
###xml 51 67 51 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 51 72 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Regulation of capsular polysaccharide synthesis in Escherichia coli K-12: characterization of three regulatory genes.
###end article-title 249
###begin article-title 250
###xml 21 37 21 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 21 42 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Capsule synthesis in Escherichia coli K-12 is regulated by proteolysis.
###end article-title 250
###begin article-title 251
Regulation and mode of action of the second small RNA activator of RpoS translation, RprA.
###end article-title 251
###begin article-title 252
Sulfa drugs strike more than once.
###end article-title 252
###begin p 253
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 253
###begin p 254
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: AKH was assisted by fellowship #08-1090-CCR-EO from the New Jersey State Commission on Cancer Research. S.T. was supported by grants from the NSF Early Career Development (CAREER) Program, Defense Advanced Research Projects Agency and National Institute of General Medical Sciences (P50 GM071508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 254

